1. Home
  2. Medical Research
  3. San Francisco, CA
  4. Glaucoma Research Foundation

Glaucoma Research Foundation

Glaucoma Research Foundation is ranked #3 of 12 medical research organizations in San Francisco, CA, with an America's Best Score of 88 out of 100, based on its 2025 Form 990.

  • San Francisco, CA
  • Tax-exempt since 1978
  • EIN: 94-2495035
glaucoma.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
88OF 100 #3 of 12 in San Francisco ranked medical research organizations How this score is calculated

Organization summary

Glaucoma Research Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H41Z). Contributions are tax-deductible.

131 Steuart St Ste 200, San Francisco, CA 94105-1242

Among the 14 scored medical research organizations in San Francisco, Glaucoma Research Foundation holds 19.9 months of operating reserves (peer median 20.7 months), runs a typical yearly surplus of 5.2% (peers: surplus of 15.0%), and has grown spending 21.5% a year (peers: grown spending 15.9% a year).

In fiscal year 2025 it reported $10,127,426 in revenue and $9,098,569 in expenses, with contributions making up 90.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

America's Best Score

Free assessmentMethodology
Score88 / 100
Rank in San Francisco#3 of 12
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves19.9 months13.8 / 25
Financial balance (median margin)+5.2%19.1 / 20
Transparency3 full 990s, latest TY202520 / 20
Program growth+21.5% / yr15 / 15
Track record48 years10 / 10
Debt load8.8% of assets10 / 10
Total87.9 → 88

Compared with San Francisco peers

MeasureThis organizationPeer median
Operating reserves19.9 mo20.7 mo
Typical margin+5.2%+15.0%
Spending growth+21.5% / yr+15.9% / yr
Debt load8.8%3.1%

Peers: the 14 San Francisco medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$10,127,426Fiscal year 20252023: $6,480,46720232024: $7,188,14720242025: $10,127,4262025
Expenses$9,098,569Fiscal year 20252023: $6,158,92720232024: $6,983,04320242025: $9,098,5692025
Total assets$16,545,749Fiscal year 20252023: $14,426,05420232024: $14,638,57720242025: $16,545,7492025
Total liabilities$1,459,454Fiscal year 20252023: $1,531,11320232024: $1,104,65520242025: $1,459,4542025
Fiscal year ending June 2025
Revenue$10,127,426
Expenses$9,098,569
Net income$1,028,857
Net assets$15,086,295

Notable sources of revenue

Percent of total revenue
Contributions$9,190,412
Program services$391,458
Investment income$343,886
Other (net)$201,670

Assets / debt

Total assets$16,545,749
Total liabilities$1,459,454
Net assets$15,086,295

Compensation

Not in our extract for this year.

Fiscal year ending June 2024
Revenue$7,188,147
Expenses$6,983,043
Net income$205,104
Net assets$13,533,922

Notable sources of revenue

Percent of total revenue
Contributions$6,473,014
Program services$460,180
Investment income$143,672
Other (net)$111,281

Assets / debt

Total assets$14,638,577
Total liabilities$1,104,655
Net assets$13,533,922

Compensation

Officers and key employees$287,531
Share of expenses4.1%
Fiscal year ending June 2023
Revenue$6,480,467
Expenses$6,158,927
Net income$321,540
Net assets$12,894,941

Notable sources of revenue

Percent of total revenue
Contributions$5,620,842
Program services$391,050
Investment income$269,430
Other (net)$199,145

Assets / debt

Total assets$14,426,054
Total liabilities$1,531,113
Net assets$12,894,941

Compensation

Officers and key employees$271,226
Share of expenses4.4%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?